June 27, 2022
Prosecutions under the Controlled Substances Act for the excessive prescribing of opioids and other addictive drugs must show that doctors knew they lacked a legitimate medical purpose, the U.S. Supreme Court ruled Monday in a defeat for the U.S. Department of Justice.
June 13, 2022
The U.S. Supreme Court said Monday it would not hear an appeal by John Kapoor, the founder of Insys Therapeutics Inc., challenging his conviction for orchestrating a scheme to bribe doctors to prescribe a powerful opioid spray.
May 16, 2022
The founder of Insys Therapeutics Inc. told the U.S. Supreme Court that a pending high court ruling could undo his conviction for orchestrating a scheme to bribe doctors to prescribe a powerful opioid spray.
March 01, 2022
The U.S. Supreme Court appeared likely Tuesday to demand stronger proof of intentional wrongdoing when the U.S. Department of Justice prosecutes opioid prescribers, according to experts, an outcome that might also help major pharmacy chains accused of recklessly selling narcotic painkillers.
February 25, 2022
It seemed like a marquee win for the U.S. Department of Justice: The felony conviction of an Alabama doctor who prescribed fentanyl in quantities so immense he may have influenced a drugmaker's stock price. But as U.S. Supreme Court justices are set to scrutinize the conviction on Tuesday, numerous scholars and corporate groups are calling it ominous and unfair, with virtually no one backing the DOJ.
January 20, 2022
The federal government has urged the U.S. Supreme Court to ignore requests from two doctors who want the justices to undo their convictions over charges related to allegedly improper prescriptions of controlled substances.
November 22, 2021
The U.S. Department of Justice's sweeping lawsuit contending that Walmart's 5,000 pharmacies "helped fuel a national crisis" of opioid abuse is being halted until the U.S. Supreme Court decides newly accepted cases involving the boundaries of Controlled Substances Act enforcement, a Delaware federal judge ruled.
November 05, 2021
The U.S. Supreme Court said Friday it would hear the appeal in the case of two Alabama doctors who were convicted of running a massive "pill mill" operation and taking kickbacks for prescribing opioids.